Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer.
JAMA 306(14):1557 (2011)
Attempts to determine the clinical significance of BRCA1/2 mutations in ovarian cancer have produced conflicting results.
Place any articles on Pubget into your Bookmark folder to read later, download citations, or send to a colleague. Create an account or sign in to create your bookmarks.